Citations

Citations to this article as recorded by  

• Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota
  Huicui Liu, Chenxi Nie, Xinzhong Hu, Juxiu Li
  Food & Function.2024; 15(3): 1250.     CrossRef
• Therapeutic applications of melatonin in disorders related to the gastrointestinal tract and control of appetite
  Atousa Moghadam Fard, Pardis Goodarzi, Mehran Mottahedi, Setareh Garousi, Hamed Zadabhari, Mohammad Kalantari Shahijan, Saeedeh Esmaeili, Mohsen Nabi-Afjadi, Bahman Yousefi
  Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(8): 5335.     CrossRef
• Bifidobacterium lactis Probio‐M8 prevents nonalcoholic fatty liver disease in high‐fat diet‐fed rats: The potential role in modulating gut microbiota
  Wen Fan, Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Maoxing Pan, Dajin Pi, Zheng Liang, Jianwei Zhen, Qinhe Yang, Yupei Zhang
  Food Bioengineering.2024; 3(1): 29.     CrossRef
• Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges
  Ernesto Saenz, Nathally Espinosa Montagut, Baohong Wang, Christoph Stein-Thöringer, Kaicen Wang, Honglei Weng, Matthias Ebert, Kai Markus Schneider, Lanjuan Li, Andreas Teufel
  Engineering.2024; 40: 51.     CrossRef
• The gut-liver axis in fatty liver disease: role played by natural products
  Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Dietary fiber intake and mortality among survivors of liver cirrhosis: A prospective cohort study
  Zahra Hariri, Azita Hekmatdoost, Fereshteh Pashayee-khamene, Sara Karimi, Salehe Ahmadzadeh, Zahra Yari
  Heliyon.2023; 9(6): e16170.     CrossRef
• The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome
  Alicia Rodríguez-Pastén, Nury Pérez-Hernández, Javier Añorve-Morga, Rubén Jiménez-Alvarado, Raquel Cariño-Cortés, Teresa Sosa-Lozada, Eduardo Fernández-Martínez
  International Journal of Molecular Sciences.2022; 23(13): 7229.     CrossRef
• Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
  Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, Meghan May, Karen L. Houseknecht
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver Disease
  Omar Ramos-Lopez
  Genes.2022; 13(11): 2142.     CrossRef
• Construction of two new polyoxometalate complexes and their recyclability in photodegradation of cephalexin and ceftiofur
  Qian-Qian Wang, Li-Hui Mao, Da-Xiang Wang, Yan-Mei Ma, Xin-Li Shi, Xi-Hao Tian
  Inorganica Chimica Acta.2022; 536: 120902.     CrossRef
• Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers
  Antonio Gil-Gómez, Paola Brescia, Maria Rescigno, Manuel Romero-Gómez
  Seminars in Liver Disease.2021; 41(02): 191.     CrossRef
• Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
  Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla
  World Journal of Hepatology.2021; 13(11): 1494.     CrossRef
• Increased Prevalence of Liver Fibrosis in People Living With Human Immunodeficiency Virus Without Viral Hepatitis Compared to Population Controls
  Ditte Marie Kirkegaard-Klitbo, Flemming Bendtsen, Jens Lundgren, Robert J de Knegt, Klaus Fuglsang Kofoed, Susanne Dam Nielsen, Thomas Benfield
  The Journal of Infectious Diseases.2021; 224(3): 443.     CrossRef
• Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
  Dragana Rajcic, Anja Baumann, Angélica Hernández-Arriaga, Annette Brandt, Anika Nier, Cheng Jun Jin, Victor Sánchez, Finn Jung, Amélia Camarinha-Silva, Ina Bergheim
  Redox Biology.2021; 41: 101879.     CrossRef
• Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis
  Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu
  Scientific Reports.2020;[Epub]     CrossRef
• Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
  Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou
  World Journal of Gastroenterology.2020; 26(16): 1901.     CrossRef
• LactobacillusandPediococcusameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome
  Na Young Lee, Sang Jun Yoon, Dae Hee Han, Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Min Jung Kwak, Byung Yong Kim, Jeong Seok Yu, Do Yup Lee, Tae-Sik Park, Si-Hyun Park, Byoung Kook Kim, Hyun Chae Joung, In Suk Choi, Ji Taek Hong, Dong Jo
  Gut Microbes.2020; 11(4): 882.     CrossRef
• Macrophages in the pathophysiology of NAFLD: The role of sex differences
  Stefano Ministrini, Fabrizio Montecucco, Amirhossein Sahebkar, Federico Carbone
  European Journal of Clinical Investigation.2020;[Epub]     CrossRef
• IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
  Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Denise Siqueira VANNI, Flair José CARRILHO, Claudia Pinto Marques Souza de OLIVEIRA
  Arquivos de Gastroenterologia.2019; 56(4): 431.     CrossRef
• Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
  Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira
  Annals of Hepatology.2019; 18(3): 416.     CrossRef
• Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance
  Toshio Maeda, Satomi Miki, Naoaki Morihara, Yoshiyuki Kagawa
  Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
• Microbiota and nonalcoholic fatty liver disease
  Christelle Knudsen, Audrey M. Neyrinck, Nicolas Lanthier, Nathalie M. Delzenne
  Current Opinion in Clinical Nutrition & Metabolic Care.2019; 22(5): 393.     CrossRef
• Gold Nanoparticles Cure Bacterial Infection with Benefit to Intestinal Microflora
  Juanjuan Li, Ruitao Cha, Xiaohui Zhao, Hongbo Guo, Huize Luo, Mingzheng Wang, Fengshan Zhou, Xingyu Jiang
  ACS Nano.2019; 13(5): 5002.     CrossRef
• Role of Gut Microbiota in Hepatocarcinogenesis
  Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Ki Tae Suk
  Microorganisms.2019; 7(5): 121.     CrossRef
• The Prenatal Microbiome: A New Player for Human Health
  Valeria D’Argenio
  High-Throughput.2018; 7(4): 38.     CrossRef
• Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
  David Porras, Esther Nistal, Susana Martínez-Flórez, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos
  Frontiers in Physiology.2018;[Epub]     CrossRef